Piper Sandler Cuts ResMed (NYSE:RMD) Price Target to $225.00

Дата публикации: 10-08-2026 05:48:47

ResMed (NYSE:RMD – Free Report) had its target price trimmed by Piper Sandler from $233.00 to $225.00 in a research report report published on Friday,Benzinga reports. The brokerage currently has a neutral rating on the medical equipment provider’s stock. RMD has been the subject of several other reports. Royal Bank Of Canada cut ResMed from […]

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	ICU Medical (NASDAQ:ICUI) Price Target Raised to $195.00	0	11.84	10-08-2026
2	Piper Sandler Cuts Molson Coors Beverage (NYSE:TAP) Price Target to $44.00	0	9.52	10-08-2026
3	Piper Sandler Cuts Restaurant Brands International (NYSE:QSR) Price Target to $81.00	0	12.25	10-08-2026
4	Teleflex’s (TFX) Overweight Rating Reiterated at Piper Sandler	0	10.31	10-08-2026
5	Piper Sandler Cuts Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target to $20.00	0	11.9	10-08-2026
6	Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $175.00	0	12.26	10-08-2026
7	STERIS’s (STE) “Overweight” Rating Reiterated at Piper Sandler	0	9.98	10-08-2026
8	Piper Sandler Cuts Papa John’s International (NASDAQ:PZZA) Price Target to $26.00	0	11.89	10-08-2026
9	Piper Sandler Cuts Celsius (NASDAQ:CELH) Price Target to $36.00	0	12.64	10-08-2026
10	Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler	0	9.05	10-08-2026

Классификация: Экономика. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 10.45. Источник: www.americanbankingnews.com.